Results 301 to 310 of about 4,166,507 (358)

Navigating the complexities of drug development for metallo-β-lactamase inhibitors. [PDF]

RSC Med Chem
Reddy N, Balieiro AM, Silva JRA, Gouws CA, Mutshembele A, Arvidsson PI, Kruger HG, Govender T, Naicker T.   +8 more
europepmc   +1 more source

Mechanism-Based Modeling Approaches to Quantify the Effect of Immunogenicity on the Pharmacokinetics of Therapeutic Proteins in Drug Development. [PDF]

CPT Pharmacometrics Syst Pharmacol
Gupta P, Ryman JT, Jawa V, Meibohm B.
europepmc   +1 more source

What's wrong with drug development for sickle cell disease? [PDF]

Hemasphere
Brousse V, Rees D, Colombatti R.
europepmc   +1 more source

Correction: Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax. [PDF]

Sci Rep
Alruwaili M, Alhassan HH, Almutary H, Tahir Ul Qamar M.   +3 more
europepmc   +1 more source

Corrin Ring Modification in Peptide Drug Development - a Brief History of "Corrination". [PDF]

ChemMedChem
Cham N, Doyle RP.
europepmc   +1 more source

Applied intelligence in clinical drug development: Potential benefits and emerging concerns. [PDF]

Perspect Clin Res
Bhatt A.
europepmc   +1 more source